NSCLC
6 competing products in clinical development for NSCLC.
Pipeline by Phase
Phase 12
Phase 1/22
Phase 21
Phase 31
All Products (6)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Bevacizumab in Combination With Paclitaxel/Carboplatin + IBI305 in Combination with Paclitaxel/Carboplatin | WuXi Biologics | Phase 3 | Completed | 37 |
| OSI-906 + Erlotinib + Placebo | Astellas Pharma | Phase 2 | Completed | 35 |
| Exisulind | Astellas Pharma | Phase 1/2 | Completed | 32 |
| Tarceva | Astellas Pharma | Phase 1 | Completed | 29 |
| BA3071 + Nivolumab + Pembrolizumab + Pemetrexed (Alimta) | BioAtla | Phase 1/2 | Active | 26 |
| BBP-398 + osimertinib | LianBio | Phase 1 | Terminated | 11 |